4//SEC Filing
Boudes Pol F 4
Accession 0001133416-23-000014
CIK 0001133416other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:37 PM ET
Size
5.3 KB
Accession
0001133416-23-000014
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-26+50,000→ 50,000 totalExercise: $1.11Exp: 2033-01-26→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest as follows: 25% on each of June 30, 2023; December 31, 2023; June 30, 2024; and December 31, 2024.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001454771
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:37 PM ET
- Size
- 5.3 KB